Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Haploidentical transplant complications: treatment approaches

Stefan Ciurea • 25 Oct 2019
COSTEM 2019
General Cyclophosphamide

Stefan Ciurea, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the most important complications of haploidentical transplant and the current treatment approaches. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Stefan Ciurea

2:45
Stem cell sources: is bone marrow preferred?
Stefan Ciurea • 25 Oct 2019
2:00
Haploidentical transplantation for AML with MRD at transplantation
Stefan Ciurea • 25 Oct 2019

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals